相似文献
1
[Characteristics of gastroesophageal reflux disease in elderly people].
Eksp Klin Gastroenterol. 2007(4):37-40.
2
[Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
Eksp Klin Gastroenterol. 2007(3):83-91.
3
[Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
Eksp Klin Gastroenterol. 2009(2):90-8.
4
Editorial: gastroesophageal reflux disease Anno 2010.
J Dig Dis. 2010 Apr;11(2):67-71. doi: 10.1111/j.1751-2980.2010.00417.x.
5
[Complications of gastroesophageal reflux and Barrett's esophagus].
Gastroenterol Clin Biol. 1999 Jan;23(1 Pt 2):S50-60.
6
Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study.
J Gastroenterol Hepatol. 2012 Apr;27(4):741-5. doi: 10.1111/j.1440-1746.2011.06921.x.
7
Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
Eur J Gastroenterol Hepatol. 2013 Jan;25(1):15-21. doi: 10.1097/MEG.0b013e3283595086.
8
Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
J Gastroenterol Hepatol. 2008 Feb;23(2):303-9. doi: 10.1111/j.1440-1746.2007.05113.x. Epub 2007 Aug 27.
9
[Efficacy of pantoprazole in the therapy of esophageal reflux disease].
Eksp Klin Gastroenterol. 2008(2):102-4.
10
[Gastroesophageal reflux disease--diagnosis and management].
Pol Merkur Lekarski. 2009 May;26(155):512-6.
Zotero 插件